Nabsys

About:

Nabsys is a life sciences company focused on the development of solid-state, single-molecule positional sequencing technology.

Website: http://www.nabsys.com

Twitter/X: nabsys

Top Investors: Slater Technology Fund, PJC, Bay City Capital, Stata Venture Partners (SVP), Hitachi High-Technologies

Description:

Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic high-definition mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to receive a “1000 Genome” award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis. It was founded in 2004 and headquartered in Providence, Rhode Island.

Total Funding Amount:

$143M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Providence, Rhode Island, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)nabsys.com

Founders:

Barrett Bready

Number of Employees:

11-50

Last Funding Date:

2022-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai